Evidence map›Paper›PMID 18047732›Full record

ArticleBMC bioinformatics2007

The alpha-hemolysin nanopore transduction detector - single-molecule binding studies and immunological screening of antibodies and aptamers.

Stephen Winters-Hilt

Abstract read
In one paragraph

Article in BMC bioinformatics, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Stephen Winters-HiltResearch Institute for Children, Children's Hospital, 200 Henry Clay Ave, New Orleans, LA 70118, USA. winters@cs.uno.edu

Funding

Nanopore study of single antibody-antigen interactionsK22LM008794 · NLM · CHILDREN'S HOSPITAL (NEW ORLEANS) · PI WINTERS-HILT, STEPHEN · 2005 to 2007
$486k
NLM NIH HHS 5K22LM008794NLM NIH HHS K22 LM008794
6 · The paper itself

Abstract

backgroundNanopore detection is based on observations of the ionic current threading a single, highly stable, nanometer-scale channel. The dimensions are such that small biomolecules and biopolymers (like DNA and peptides) can translocate or be captured in the channel. The identities of translocating or captured molecules can often be discerned, one from another, based on their channel blockade "signatures". There is a self-limiting aspect to a translocation-based detection mechanism: as the channel fits tighter around the translocating molecule the dynamic range of the ionic current signal is reduced. In this study, a lengthy, highly structure, high dynamic-range, molecular capture is sought as a key component of a transduction-based nanopore detection platform.

resultsA specialized role, or device augmentation, involving bifunctional molecules has been explored. The bifunctional molecule has one function to enter and blockade the channel in an information-rich self-modulating manner, while the other function is for binding (usually), located on a non-channel-captured portion of the molecule. Part of the bifunctional molecule is, thus, external to the channel and is free to bind or rigidly link to a larger molecule of interest. What results is an event transduction detector: molecular events are directly transduced into discernible changes in the stationary statistics of the bifunctional molecule's channel blockade. Several results are presented of nanopore-based event-transduction detection.

conclusionIt may be possible to directly track the bound versus unbound state of a huge variety of molecules using nanopore transduction detection.

Indexed as

TransducersAntibodiesAptamers, NucleotideBacterial ToxinsBiosensing TechniquesEquipment DesignEquipment Failure AnalysisHemolysin ProteinsImmunoassayNanotechnologyPorosityReproducibility of ResultsSensitivity and SpecificityAntibodiesAptamers, NucleotideBacterial ToxinsHemolysin Proteinsstaphylococcal alpha-toxin

Identifiers

PMID18047732
PMCPMC2099501

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.